NEW YORK (GenomeWeb) — Becton Dickinson will distribute AITbiotech's molecular assays in the Asia-Pacific region, the companies said late last week.
Under the agreement, Becton Dickinson Holdings, BD's Singapore-based subsidiary, will distribute AITbiotech's abTES BM qPCR assays optimized for use on the BD Max molecular testing system.
The abTES BM assays are manufactured at AITbiotech's ISO13485 certified facilities in Singapore. Currently, AITbiotech offers research-use-only assays for the detection of Chlamydia trachomatis/Neisseria gonorrhoeae, herpes simplex virus 1/HSV 2/varicella-zoster virus, and Mycobacterium tuberculosis.
"Our agreement with AITbiotech represents a key milestone in BD's strategy to make the BD MAX System an indispensable laboratory tool that empowers laboratory professionals to provide rapid and accurate test results," Glen Costin, business director for molecular and cancer diagnostics in Asia Pacific at BD Diagnostics, said in a statement.